In an effort to examine how SUMOylation modifies the functional landscape of GBM we recently utilized liquid chromatography (LC)/mass spectrometry (MS)/MS analysis to examine changes in SUMO-1 conjugated proteins in response to inhibition of SUMOylation [87]. Here, SUMO1 is linked to glioblastoma.